Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia
efgartigimod(一种新型FcRn拮抗剂)治疗原发性免疫性血小板减少症成年患者的II期研究
期刊:American Journal of Hematology
影响因子:9.9
doi:10.1002/ajh.25680
Newland, Adrian C; Sánchez-González, Blanca; Rejtő, László; Egyed, Miklos; Romanyuk, Nataliya; Godar, Marie; Verschueren, Katrien; Gandini, Domenica; Ulrichts, Peter; Beauchamp, Jon; Dreier, Torsten; Ward, E Sally; Michel, Marc; Liebman, Howard A; de Haard, Hans; Leupin, Nicolas; Kuter, David J